Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 8 papers were listed this time. Here's a handful:
Lee WC, Conner C, Hammer M. Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US. Curr Med Res Opin. 2011 Feb 25. [Epub ahead of print] PubMed PMID: 21348806.
Kamae MS, Kamae I, Cohen JT, Neumann PJ. Regression analysis on the variation in efficiency frontiers for prevention stage of HIV/AIDS. J Med Econ. 2011 Feb 18. [Epub ahead of print] PubMed PMID: 21332273.
Eckard N, Janzon M, Levin LA. Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies. Scand Cardiovasc J. 2011 Feb 17. [Epub ahead of print] PubMed PMID: 21329415.
Beckwith J, Nyman JA, Flanagan B, et al. A health economic analysis of clinical islet transplantation. Clin Transplant. 2011 Feb 16. [Epub ahead of print] PubMed PMID: 21323736.